EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Benefits and Harms of Dose Escalation of Inhaled Corticosteroids in Uncontrolled Asthma

Arnaud Bourdin, Richard Beasley, Anju T Peters, Mario Castro, Njira L Lugogo, Olivier Ledanois, Antonio Martin, Yamo Deniz, Melissa Iammatteo, Mena Soliman, William W Busse

The Journal of Allergy and Clinical Immunology: In Practice · 2026-10

DOI: 10.1016/j.jaip.2026.09.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-10. Verfasst von Arnaud Bourdin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, PhyMedExp, University of Montpellier, INSERM CNRS, Montpellier, France. Electronic address: arnaud01009157@gmail.…. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi US, Regeneron Pharmaceuticals Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AsthmaBenralizumabBiologicsDupilumabInhaled corticosteroidsOmalizumabSide effects

Autor:innen und Institutionen

  • Department of Respiratory Diseases, PhyMedExp, University of Montpellier, INSERM CNRS, Montpellier, France. Electronic address: arnaud01009157@gmail.com.
  • Medical Research Institute of New Zealand, Wellington, New Zealand; Capital, Coast and Hutt Valley District Health Board, Wellington, New Zealand; School of Biological Sciences, Victoria University Wellington, Wellingto…
  • Allergy-Immunology Division and the Sinus and Allergy Center, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Department of Medicine, University of Kansas School of Medicine, Kansas City, Kan.
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Mich.
  • Sanofi, Paris, France.

Förderung

  • Sanofi US
  • Regeneron Pharmaceuticals Inc

Zitieren

APA

Bourdin, A., Beasley, R., Peters, A. T., Castro, M., Lugogo, N. L., Ledanois, O., Martin, A., Deniz, Y., Iammatteo, M., Soliman, M., & Busse, W. W. (2026). Benefits and Harms of Dose Escalation of Inhaled Corticosteroids in Uncontrolled Asthma. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.09.034

Vancouver

Bourdin A, Beasley R, Peters AT, Castro M, Lugogo NL, Ledanois O, et al. Benefits and Harms of Dose Escalation of Inhaled Corticosteroids in Uncontrolled Asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.09.034

BibTeX
@article{Bourdin2026,
  author = {Bourdin, Arnaud and Beasley, Richard and Peters, Anju T and Castro, Mario and Lugogo, Njira L and Ledanois, Olivier and Martin, Antonio and Deniz, Yamo and Iammatteo, Melissa and Soliman, Mena and Busse, William W},
  title = {Benefits and Harms of Dose Escalation of Inhaled Corticosteroids in Uncontrolled Asthma},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2026.09.034}
}
Kostenlos starten →